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ABSTRACT
ASSOCIATIONS OF SHORT AND MEDIUM CHAIN SATURATED FATTY ACIDS AND
DAIRY WITH COGNITIVE FUNCTIONING IN THE BOSTON PUERTO RICAN HEALTH
STUDY
By
Sophie M. Kenny
University of New Hampshire

Cognitive decline is a major public health concern. Evidence suggests that
Hispanic/Latino adults, specifically Puerto Rican adults, in the US are at a higher risk of
developing dementia or cognitive decline due to the high prevalence of risk factors, including
cardiovascular disease and diabetes. Emerging evidence suggests that specific dietary fatty acids,
short and medium-chain-length saturated fatty acids, that are found in dairy may be beneficial for
cognitive function. However, there are limited observational studies examining the effects of
SMCSFA and dairy on cognitive function in Hispanic/Latino adults. We examined the crosssectional and prospective associations between SMCSFA and dairy consumption with cognitive
function among Puerto Rican adults.
Data were from the Boston Puerto Rican Health Study (57 yrs, 71% female), an ongoing
prospective cohort study. Diet was assessed using a validated food frequency questionnaire.
Dairy products included milk, cheese, yogurt, cream, and butter. Our primary exposures were the
sum of SMCSFA(%TE), a dietary fatty acid pattern consistent with high SMCSFA, total dairy
(s/d), regular & reduced fat dairy (s/d), and nonfat dairy products (s/d). A battery of
neurocognitive tests was administered by trained staff in the language of preference. Global
cognitive function score (GCS) was calculated as the mean z-scores of the individual tests. A
subset of BPRHS participants returned for neurocognitive testing at 13-yr follow-up. We

analyzed SMCSFA in a substitution analysis at the expense of trans fats and added sugar. Dairy
models were adjusted for total energy, age, sex, physical activity, smoking status, and education.
We also conducted a substation analysis of dairy at the expense of red and processed meats. Our
cross-sectional analysis was conducted using multivariate linear regression. Our prospective
analysis assessed the change over baseline, 2 and 13 years using a mixed effects model with
time-covarying covariates.
In the final sample, participants consumed 2.42 s/day of dairy and less than 1% of their
diet was derived from SMCSFA. Most dairy was consumed through 2% and whole milk (37%).
Most SMCSFA in the diet were derived from cheese (30%) and whole milk (22%). Butter was
significantly related to GCS over 13 years of follow-up. There were no significant associations
between SMCSFA, total dairy, regular & reduced fat dairy, or nonfat dairy with cognitive
function cross-sectionally or prospectively.
In this cohort of Puerto Rican adults, our findings suggest there were no associations between
SMCSFA and dairy with cognitive function. Future prospective studies should examine this relationship
in a similar population with larger sample sizes and over a longer duration.
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INTRODUCTION
Dementia is a major public health concern.a In the U.S., it is one of the top five leading
causes of premature mortality.2 An estimated one in nine adults suffer from cognitive
decline.3 Cognitive impairment is costly to the individual with medical costs ranging from
$6,000 to over $100,000 a year and upwards of $305 billion annually to the United States.4-7
Beyond financial concerns, the World Health Organization (WHO) recognizes that those living
with dementia have an impaired quality of life, as well as an increased risk of other
cardiometabolic diseases.8-10 There is strong interest in dietary fat intake as a modifiable risk
factor for cognitive decline because of documented effects on related chronic health conditions,
including cardiovascular disease (CVD).11 It is widely recommended to moderate the intake of
saturated fat to reduce the risk for heart disease and stroke, however, current evidence on the
impact of saturated fat consumption in relation to cognitive function remains inconclusive with
reports of adverse and null associations.12 These results may be partly because previous
investigations of saturated fat and cognitive function or dementia, examined total saturated fat
consumption rather than considering the individual species that make up the saturated fat class.12
Saturated fatty acids (SFA) can be differentiated by the number of carbons that make up
the hydrocarbon tail, which include short (<6 carbons), medium (7 to <12 carbons), long (12 to
20 carbons), and very-long (>20 carbons) chain SFA species.13 Building evidence from
epidemiological and animal studies suggests that short and medium-chain-length SFA may
benefit metabolic pathways implicated in cognitive decline, including inflammation and insulin
resistance.14-17 In a recent randomized control trial (RCT), researchers observed improvements

a

Dementia is defined by the Alzheimer’s Association as “a group of symptoms associated with a decline in
memory, reasoning or other thinking skills” whereas Alzheimer’s disease is “a degenerative brain disease that is
caused by complex brain changes following cell damage”. 1
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in insulin resistance among participants when consuming medium-chain SFAs (MCSFA), as
compared to long-chain SFAs (LCSFA).18 In the European Prospective Investigation into Cancer
and Nutrition-Netherlands Cohort, investigators found that over 12 years, there was an
association between lower ischemic heart disease and short-chain SFAs (SCSFA) and MCSFA
consumption.19 These included butyric acid (C4), capric acid (C10), pentadecanoic acid (C15),
margaric acid (C17), and myristic acid (C14), which are SFAs found in varying amounts in dairy
products.20 There is a vast knowledge base of research conducted regarding fat consumption and
CVD suggesting there may be an association between CVD and cognitive function. 21, 22
However, there is a paucity of data available on the potential impact of SCSFA and MCSFA
dietary consumption on cognitive function.
Current recommendations and studies regarding fat consumption compare total SFAs to
unsaturated fatty acids. Similar to that CVD recommendations, available systematic reviews and
meta-analyses have reported adverse and null associations between total SFA and cognitive
function.5,23 This may be due to most previous studies not examining the specific chain length
groups of SFAs. Although SFAs as a class of fats have been investigated concerning cognitive
function and dementia, the results remain inconclusive. Our preliminary data in the Hispanic
Community Health Study/Study of Latinos (HCHS/SOL) suggests that SCSFA and MCSFAs
may benefit cognitive function, as they were associated with a higher global cognitive function
score. 24 Of note, dairy products were the main contributor to SCSFA and MCSFA consumption
among the study participants. Studies of food SCSFA and MCSFA in food sources, including
dairy, have shown some benefits with cognitive outcomes, but further investigation is needed.25
To our knowledge, our previous work in the HCHS/SOL is the first epidemiological study to
investigate SCSFA and MCSFA in relation to cognitive function. However, these findings were
2

cross-sectional in nature, and a prospective study design with repeated measures of diet and
cognitive function was needed to replicate this novel finding.
Although few data are available, some evidence suggests that Hispanics/Latinos may be
disproportionately burdened by dementia and risk factors of cognitive decline. Current research
estimates that Hispanics/Latinos experience a 47% higher prevalence of dementia as compared to
non-Hispanic Whites.26 It has been reported that Puerto Ricans have a greater prevalence of
CVD compared to Mexicans, and are just below in type 2 diabetes as compared to Mexicans, the
largest group of Hispanics/Latinos living in the United States.27,28 Moreover, a limited number of
studies have been conducted in Hispanic/Latino cohorts examining the relationship between diet
and cognitive function. 29, 30 Additional studies examining these associations are necessary to
inform culturally specific dietary recommendations and interventions to reduce the burden of
cognitive decline. 31,32
Considering the current evidence, we hypothesized that SMCSFA and their food source,
regular and reduced-fat dairy products, would be beneficially related to cognitive functioning in
Puerto Rican adults. The primary objective of this study was to examine the prospective
relationship between dairy fat and dairy products with cognitive functioning over 13 years.
Secondarily, we examined the associations of SMCSFA and dairy products with cognitive
function cross-sectionally at baseline.

3

BACKGROUND
Public Health Relevance
According to Behavioral Risk Factor Surveillance System data collected between 2015 to
2017, 11.1% of Americans reported having a form of cognitive decline.3 Furthermore, dementia
disproportionally affects Hispanic/Latinos residing in the United States.3 Chen and
Zissimopoulous 26 used the Health and Retirement Study cohort to examine associations between
race and cognition. The investigators found that as of 2012, the prevalence of dementia in the
Hispanic/Latino population was 16.7%, compared to that of the non-Hispanic White population
with a 7.4% prevalence. From 2000 to 2012, a 25% decrease in cognitive decline prevalence was
seen in both African American and non-Hispanic White respondents, but this decrease was not
observed in the Hispanic/Latino population. Instead, it remained stagnant for the majority of the
study.
Short and Medium Chain Saturated Fat and Risk Factors of Cognitive Decline
Dietary fat intake and its relationship with CVD have been widely investigated.
According to the Guidelines set by the US Department of Agriculture (USDA) it is
recommended to consume less than 10% of calories from dietary saturated fat.11 In 2017, the
American Heart Association (AHA) released a Presidential Advisory regarding saturated fat
intake and the risk of CVD.33 The advisory was consistent with other recommendations in that
saturated fat as a whole should be replaced with unsaturated fats. The advisory addressed three
specific saturated fats, lauric acid (C12), myristic acid (C14), and palmitic acid (C16). A 2017
systematic review and regression analysis published by the WHO, found that these SFA were
associated with raising HDL and LDL cholesterol.34 This evidence suggests that these specific
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SFA may have negative health impacts, but the study did not look at the SFAs with less than 12
carbons.
Emerging evidence suggests SCSFA and MCSFA may have positive impacts on
cardiometabolic risk factors, including insulin resistance and inflammation.18,35,36 The most
abundant SCSFA in the diet is butyrate (C4), which is found in milk, cheese, and yogurt.37 In a
recent animal RCT, sodium butyrate (NaB) was administered to mice to examine its implications
on endothelial dysfunction, a major contributor to atherosclerosis.35 Researchers found that mice
receiving NaB decreased reactive oxygen species (ROS) and inhibitors of nitric oxide.
Furthermore, mice were treated with interleukin-1 beta (IL1-β) to induce a state of inflammation
and the administration of NaB downregulated ROS production in the IL1-β treated mice. An
RCT out of the University of Copenhagen, analyzed the effects of MCSFA on insulin resistance
in 17 men.18 The subjects either consumed a control diet (63% carbohydrate, 14% protein, and
34% fat) or one of the two experimental diets, one with a 75% increase in energy and 82% of
calories derived from LCSFA. The second experimental group was similar to the first, but 5% of
the LCSFA were replaced with MCSFA. The LCSFA group reduced insulin sensitivity and
insulin-stimulated glucose disposal, whereas the group with 5% MCSFA did not see the same
impairments. In a recent animal RCT study, it was found that a ketogenic diet (KD) containing
MCSFA was negatively associated with mTOR, a regulatory pathway of insulin and insulin-like
growth factors.36 Research suggests that reduced mTOR activity may improve insulin
sensitivity.36 The KD high in MCSFA was also associated with lower levels of serum tumor
necrosis factor-alpha (TNF-α), an indicator of inflammation, compared to the diet groups with
lower dietary MCSFA. These studies suggest the potential benefits of MCSFA as a replacement
for LCSFA.
5

Evidence suggests there is a link between CVD and cardiometabolic risk factors with
cognitive decline.38 A 2017 recent systematic review and meta-analysis examined the effects of
cognitive impairment and heart failure.39 It was found that among the heart failure patients that
were included in observational studies, approximately 40% had cognitive impairment. A separate
systematic review and meta-analysis found that coronary heart disease was prospectively
associated with cognitive decline or dementia.40 A prospective study conducted in Australia,
(n=77) assessed cognitive function in adults over 45 years old who had chronic heart failure class
I, II, or III.41 Significant cognitive decline was observed over the two years. It is hypothesized
that the link between CVD and cognitive impairment may be due to the nitric oxide (NO)
pathway. NO is necessary for brain signaling and functioning. Inflammation and insulin
resistance decrease endothelial cell function for these brain processes by downregulating the
production of NO.42 Furthermore, CVD can cause detriments to the structure of the brain,
including alterations to the hippocampus, as well as increased white matter lesions, cerebral
infarcts, micro-bleeds, and gray matter atrophy, thus leading to cognitive impairment.41,43
The relationship between CVD and cognitive function suggests there may be an
association between dietary fat intake and cognitive function. At this point, the data are
inconclusive due to substantial variation and heterogeneity in methodology when comparing
SFAs and cognitive function.12 A recent systematic review and meta-analysis comparing total fat,
SFA, MUFA, and PUFA, found that SFAs as a whole may be associated with lower cognitive
function.12 Evidence regarding specific chain lengths of SFA implies that there may be a positive
association between SCSFA and MCSFA and cognitive function.
The data are limited regarding the effects of specific chain length dietary SFA, but
emerging evidence is suggesting SCSFA may be associated with improved cognition. One
6

proposed biological mechanism of SCSFA improving cognitive function is through the inhibition
of histone deacetylase. When SCSFA are absorbed into the colon, they may inhibit histone
deacetylase.44,45 SCSFA can bind to a G protein-coupled receptor and act as a ligand, inhibiting
histone deacetylase.45 Histone acetylation is a part of gene expression during normal cognitive
function, and histone deacetylase disrupts this. Histone deacetylase causes a buildup of amyloidβ plaques in the brain, which is a diagnostic criterion for Alzheimer's disease (AD).44 The
inhibition of histone deacetylase may decrease amyloid-β plaque formation and therefore may
improve cognitive function. SCSFA’s ability to promote histone acetylation has also been linked
to anti-inflammatory and neuroprotective effects.45
In a recent animal RCT, mice underwent a 12-week intervention of sodium butyrate
(NaB) administration, an SCFSA, either being assigned to the control group or receiving 5mg
NaB/kg/day or 15mg NaB/kg/day.41 The mice included were in an early stage of AD,
characterized by the concentration of amyloid-β peptides. At the end of the study, a 40%
decrease in amyloid-β peptide was observed in both experimental groups compared to the
control, suggesting potential benefits of NaB on cognitive function. An earlier study in 2011 also
found NaB inhibited histone deacetylase and improved cognitive decline when administered at a
later stage of AD in mice.46 Interestingly, an RCT examined mice who underwent cecal ligation
and perforation surgery, which increased histone deacetylase, impairing memory and cognitive
function.47 NaB was administered and an improvement in cognition was observed. More research
is needed to determine the effects of SCSFA in humans.
MCSFAs have been examined in in-vitro, animal, and experimental research. It is
hypothesized that MCSFA may reduce oxidative stress, which is associated with decreased
endothelial and brain cell function and cell death.48A recent in-vitro study examined the effects
7

of MCSFA, capric acid (C10) versus a LCSFA, eicosanoid acid (C20), on oxidative stress
measured through Reactive Oxygen Species (ROS), superoxide radical anion (O2•-), and
hydrogen peroxide (H2O2). Researchers found that cells that received C10 significantly
decreased intracellular O2•- and H2O2 released, compared to cells receiving C20. O2•- is an ROS
that is released from the mitochondrial electron transport chain. The enzyme superoxide
dismutase (SOD1) is responsible for converting O2•- to H2O2, which is associated with cell
death. Authors suggest that C10 downregulates the conversion of O2• through inhibiting SOD1
and stimulates two enzymes that detoxify H2O2 into water and oxygen. This would decrease the
amount of ROS in cells, therefore decreasing the amount of cell death, and improving endothelial
cell function. A recent RCT examined the effects of an MCSFA supplement, containing both
caprylic acid (C8) and C10 in older adults (n=64) over 3 months.49 The data suggested the
MCSFA had positive impacts on cognitive function, measured by the Mini-Mental State
Examination (MMSE). Also of note, MMSE scores decreased in the participants who took an
LCSFA supplement. In an earlier RCT in elderly adults (n=38), investigators found that MCSFA
in combination with the amino acid leucine and cholecalciferol, cognitive function scores
measured by MMSE improved by 10.6%, compared to the diet with leucine and LCSFA, which
decreased by 11.2%.50
Some evidence suggests that MCSFAs may have benefits on cognitive function due to
the availability of ketones, created through ketosis. Ketones are considered the preferred energy
source for the brain during times of low glucose availability, such as during a prolonged fasting
period or with insulin resistance.51 In an RCT examining individuals with Mild Cognitive
Impairment (MCI) (n=52), participants were blindly randomized into either a control group, who
received a placebo, versus an experimental group who received 30 grams of a ketogenic
8

medium-chain triglyceride (kMCT) for 6 months.51 There was an association between the
increases in plasma ketones, derived from the kMCT, and improved scores in the Trail Making
Test, Verbal Fluency, and Boston Naming Test, all three tests of cognitive function. This study
hypothesized that MCI may be associated with lower energy status in the brain. KMCT increased
the prevalence of serum ketones, increasing the energy available to the brain in the form of
ketones, as opposed to glucose. In a similar study conducted in a Japanese cohort (n=20) the
participants consumed a ketogenic formula containing 20g of MSCFA, composed of both
caprylic acid (C8) and capric acid (C10).52 Participants completed cognitive tests 120 minutes
following consumption. Over 2-3 months, there were positive associations between the ketogenic
MCSFA formula in working memory, short-term memory, and processing speed. In 2016, a
prospective clinical intervention in a Japanese cohort (n=22) examined the impacts of Anoxa, a
medical food that contains 20g of C8.53 Improvements in cognitive measures were observed in
patients who did not have the Apolipoprotein, a genetic trait associated with Alzheimer’s
disease, and a low MMSE score (>14). In 2017, this study was reanalyzed to determine which
aspects of cognitive function Anoxa did impact.53 Researchers found that the MCSFA
supplement improved memory and orientation, but only in patients in the early stages of MCI.
Animal studies were also conducted to explore the relationship between MCSFA and
cognitive function. A study was conducted on a sample of dogs because cognitive dysfunction in
dogs parallels that of dementia in humans.54 Similar to studies conducted in humans, it was
found that dog’s cognitive function significantly improved when given an MCSFA supplement
over 90 days, measured by owners’ reports of different cognitive measures, including
disorientation, altered social interaction, anxiety, sleep-wake cycle disturbance, house training,
learning and memory, and altered activity. In an RCT conducted on mice, C10 was associated
9

with improved novel object recognition.55 From the research, MCSFA may be beneficial to
cognitive function.
Dairy and Cognitive Function
Dairy is a food source containing both SCSFA and MCSFA. In one cup of whole milk,
there is roughly 1 g of SCSFA and 4 g of MCSFA.20 Current research on dairy intake and
cognitive function is inconclusive due to varying methodology and dairy types examined. A
cross-sectional study conducted using the Maine-Syracuse Longitudinal Study cohort (n=972)
found that there was a linear trend between the frequency of dairy consumption and cognitive
function, measured through a battery of neurocognitive tests.56 Similarly, in an RCT comparing
diets with high quantities of dairy to low quantities of dairy, investigators found that working
memory via the Spatial Span Backwards test was significantly lower in those consuming the
lower quantities of dairy as compared to those consuming the high dairy diet.57 Although it
seems dairy may be beneficial for cognitive function, it remains inconclusive because these
studies compared total dairy to cognitive function, as opposed to low-fat dairy and high-fat dairy.
In a recent cross-sectional study consisting of older Dutch adults (n=619), dietary data was
collected via a 190-item Food Frequency Questionnaire (FFQ).58 Global cognitive function was
measured through a battery of cognitive function tests and a z-score was used to calculate a
compound score. It was found that there was an association between higher levels of fermented
dairy products, as well as skimmed dairy with higher executive functioning scores. There were
no associations observed between total dairy consumption, full-fat dairy, or non-fermented dairy.
The investigators did find that fermented dairy products, including buttermilk, may be associated
with higher cognitive functioning due to the lactic acid bacteria and the probiotic benefits they
provide to the gut-brain axis. The skimmed dairy may have shown benefits for cognitive function
10

because of nonfat components, including vitamin D, vitamin B-12, and calcium.59 A recent
prospective study in an elderly Japanese population (n=237) found that lower baseline intake of
milk was associated with cognitive decline in men.60 This study did not specify which fat types
of milk. In a separate prospective study in a similar population of elderly Japanese men
(n=1,081), the researchers found a significant inverse relationship between milk and dairy intake
and cognitive function, but did not differentiate between dairy fat type.61 Over the course of 20
years, a prospective study using the Atherosclerosis Risk in Communities (ARIC) Cohort
(n=13,751), an association between milk intake and cognitive decline was observed, but this
study specifically examined low-fat milk and skim milk.62 However, a cross-sectional study
conducted in a Chinese population (n=3670) found that low-fat milk was associated with higher
cognitive function in women.63 At this time, the data is conflicting. More research is needed to
determine the effects specifically of full-fat dairy and cognitive function.
The data on cognitive function and dietary SCSFA and MCSFA are limited, especially in
the Hispanic/Latino population. Our preliminary work investigated dietary fatty acids and
cognitive function in the HCHS/SOL population in a cross-sectional study.24 Karazurna et al
found that SCSFA and MSCFA were associated with higher global cognitive function.24 To our
knowledge, the current study is the first to prospectively examine the impacts of SCSFA and
MCSFA and specific dairy fat types on cognition in an older Puerto Rican population. Our
findings present novel evidence to inform future dietary guidelines regarding dairy and specific
saturated fatty acids in Hispanic/Latino adults living in the US

11

METHODS
Participants
Data were derived from the Boston Puerto Rican Health Study (BPRHS), an ongoing
cohort study conducted out of the Greater Boston Area. The study aims to examine the
relationship between psychosocial stress and related health outcomes, including cognitive
function and depression.64 Diet and cognitive function were measured at baseline, 2 years, and 8
years. As previously reported, participants were an average of 55 years of age and mostly female
75-78% at baseline and 13 years, respectively.64 Participants were recruited through the 2000 US
census tracker, flier distribution at local events such as fairs, or festivals, television, and radio
advertisements, or by personal referral to the study. Inclusion criteria for this study included selfidentification as Puerto Rican descent in the census, the ability to answer study questions in
either English or Spanish, between 45 and 75 years old, and living in the metropolitan area of
Boston. Exclusion criteria included missing dietary, cognitive, or covariate data, serious health
conditions in which the individual could not answer questions, the plan to move from the area
within 2 years, or a score below 10 on the MMSE.64 All participants provided written informed
consent. The BPRHS was approved by the Institutional Review Board at Tufts Medical Center,
Northeastern University, and the University of Massachusetts Lowell.64
Assessment of Dietary Intake
Dietary intake was measured at baseline, 2, and 13 years by a 126-item validated semiquantitative FFQ, which included frequency and portion size questions for an extensive list of
foods.64 The questionnaire was based on the National Cancer Institute-Block FFQ and was
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adapted for a more accurate representation of the Puerto Rican population.64 Food amounts were
linked to the Nutrition Data System for Research (NDSR), to estimate the nutrient intakes.65
SCSFA and MCSFA were defined as those with <6 carbons and 7 to ≤12 carbons,
respectively (Supplementary Table 1). Dietary fatty acids were expressed as a percent of total
energy. Our primary fatty acid exposure was total short and medium-chain SFA, calculated as
the sum of these fatty acids per day.
Dairy products of interest included milk, yogurt, cheese, cream, and butter. One serving
of milk, yogurt, cheese, cream, and butter were 1 cup, 1 cup, 2 oz, 1 tbsp, and 1 tsp, respectively.
Dairy intake was estimated by merging BPRHS diet data with the NDSR nutrient database to
extract servings per day of each individual food item per person. Nine food items were not
available in NDSR, including vegetarian lasagna, pasta with pesto sauce, and pasta with clam
sauce, amongst others. Furthermore, dairy desserts, including ice cream, frozen yogurt, pudding
and others, loaded onto dairy-based dessert categories, as opposed to dairy categories. To
estimate dairy in these food items, we utilized the USDA nutrient database. The USDA nutrient
database provided servings/100g of milk, cheese, and yogurt per food item, which was consistent
with the NDSR. However, the USDA did not provide servings of butter or cream, so this was
estimated by calculating the gram amount of cream and/or butter through recipes and extracting
this value from the solid fat servings from the USDA database. This gram amount was then
multiplied by grams per serving to identify the number of servings of butter and cream included
in each food item.
The primary dairy exposures were total dairy (milk, yogurt, cheese, butter, and cream),
regular and reduced-fat dairy, and nonfat dairy. They were expressed as energy-adjusted servings
13

per day. Regular and reduced-fat dairy was defined as any of the previously mentioned dairy
products that contained fat, including whole fat, 2%, 1%, or labeled as reduced fat. Nonfat dairy
was defined as products with 0% fat or labeled as skim. Dairy exposures were expressed as
energy-adjusted servings per day by dividing the total servings by total energy (kcal) and
multiplying by 2000 (kcal).
Dietary Fatty Acid Pattern
We utilized the factor loading score that was consistent with high SMCSFA intake,
previously derived in Karazurna et al.24 This factor loading score was developed using principal
component analysis with varimax rotation (proc factor in SAS). This analysis is used commonly
in nutritional epidemiology to identify patterns of nutrient intake.66 The input variables included
were dietary fat represented as total fat, 26 specific fatty acids, and MUFAs from plant and
animal sources, which were calculated similarly to previous studies.67 Plant MUFAs were
determined to be from fruit, vegetables, grains, and legumes. Animal MUFAs were from meat,
animal fat products, and dairy products. MUFAs from food items that had both plant and animal
sources, such as pizza, were calculated through recipes by calculating gram amounts of each
MUFA source and determining the proportion from plants versus animals.
Neurocognitive Testing
Neurocognitive tests were administered at baseline, 2 and 13-year follow-ups. Cognitive
function was measured through a battery of tests including two Word List Learning tests, Digit
Span Forward and Backwards, three Stroop tests, Verbal Fluency, Clock Drawing, and Figure
Copying.29 Cognitive tests were conducted by trained interviewers in the language of the
participant’s preference (Spanish or English). The Word List Learning tests included an
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immediate recall, where participants were asked to repeat a list of words that were read to them
immediately prior and were given five attempts to do so. This test aimed to measure verbal
memory.68 The second component of Word List Learning was to measure retention and
recognition, in which the participant identified words that were included in a previous list. Digit
Span forward and backward were administered to measure attention and working memory.68
These tests required the participant to repeat a list of numbers that were read to them in the order
they were given or in reverse, respectively. There were three Stroop Tests to quantify processing
speed, cognitive flexibility, and response to inhibition.68 Stroop Tests 1 and 2 required the
participant to read a list of words as fast as possible within a 45-second time frame. Stroop test 3
requires the participant to name the color of a word as fast as they can in a 45-seconds.69 Verbal
fluency tested English language fluency and executive functioning by asking the participants to
name as many words as they can think of with the letter C and was repeated two more times with
the letters F and L.68 Clock drawing and figure copying both were assessing visual-spatial
organization by requiring the participant to draw a clock with a specific time, and eight different
figures that were described by the administrator of the test.70,71
Consistent with previous studies of diet and cognitive function, we calculated a global
cognitive function including the aforementioned cognitive tests.72 The composite score was
calculated by standardizing each individual test through a z score transformation, and the average
of these scores created the global score.69,72
Covariates
Sociodemographic covariates that were collected at baseline, 2 years, and 13 years
included sex (male/female)53,59,68,73, age (years)50,59,61,64,75,, education level (< high school or high
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school graduate)53,64, smoking status (yes/no)53,59,75, and physical activity level score59,68, which
was measured by a modified version of the Paffenbarger questionnaire, which calculates a score
based off of all activities within the past 24 hours.75 Clinical covariates included self-reported
diabetes status (yes/no)53,65,66 and CVD status (yes/no). 52,74
Dietary covariates were considered confounding variables and to hold constant for
substitution models. Potential confounding dietary covariates included total energy (kcal/day),
fruit (s/day), vegetable (s/day) added sugar (%TE), MUFA (%TE), PUFA (%TE), VLCSFA
(%TE) and LCSFA (%TE).73 Substitution model covariates further included total carbohydrates
(%TE), total fat (%TE), total protein (%TE), total alcohol (%TE), trans fatty acids (%TE),
carbohydrates without added sugar (%TE), summed servings of grains, fruit, vegetables, animal
proteins without red meat, dairy, legumes, oils, and alcohol. 76
Statistical Analyses
Data were examined by histograms and transformation was applied when necessary.
Means and proportions were used to report baseline dietary, cognitive, and demographic data.
Our primary analyses were repeated-measures linear mixed-effects models fitted to assess
SMCSFA and dairy intakes at baseline with 2-year and 13-year changes in overall cognitive
function and individual neurocognitive tests. (n=345). We examined the prospective associations
between SMCSFA and cognitive outcomes using a substitution analysis at the expense of trans
fatty acids, holding total energy (kcal), fat(%TE), carbohydrate (%TE), protein (%TE),
alcohol(%TE), LCSFA(%TE), VLCSFA(%TE), MUFA (%TE), and PUFA (%TE) intake
constant, as well as adjusting for age, sex, education level, smoking status, and physical activity
level. We also conducted a substitution analysis at the expense of added sugar, adjusting for all
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the trans fatty acid model covariates plus total carbohydrates minus those from added sugar, and
trans fats. We also conducted a prospective model with the factor score loading onto SMCSFA
derived from Karazurna et al.24. In this model, we adjusted for age, sex, education level, and time
covarying total energy, physical activity, and smoking status.
Dairy exposures were also analyzed with repeated-measured linear mixed-effects models
assessing the changes from baseline to 2 and 13 years with overall cognitive function and
individual neurocognitive tests. Model 1 was adjusted for age, sex, and time covarying total
energy, physical activity level, smoking status, and physical activity level. Model 2 was adjusted
for model 1 covariates plus time covarying fruit, vegetable, and added sugar consumption.
Because of the documented effects of SMCSFA and CVD and insulin resistance on cognitive
function39,74 we conducted a third model adjusting for CVD and diabetes status to identify
potential mediation.
Secondary analyses included cross-sectional linear regression models at baseline. Similar
to our prospective analyses, we conducted substitution models with SMCSFA and cognitive
outcomes at the expense of trans fats and added sugar, as well as the SMCSFA factor loading
score. We adjusted for the baseline measures of the covariates mentioned previously (n=1,292).
We also examined our dairy exposures cross-sectionally, adjusting for the baseline measures for
each model mentioned previously.
We conducted a variety of additional analyses. Dairy has previously been defined as
milk, cheese, and yogurt, excluding dairy desserts.58,59, We repeated each of our analyses with
dairy defined as the sum of milk, cheese, and yogurt energy-adjusted servings per day. We also
conducted a prospective substitution analysis with dairy at the expense of red and processed
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meats. This was done by holding total energy, and the sum of total servings of fruit, vegetables,
legumes, and animal proteins without red and processed meat, grains, and oils constant at each
time point, as well as adjusting for age, sex, education level, and time covarying physical activity
level and smoking status.
To adjust for multiple hypothesis testing and reduce the risk of Type 1 errors, we utilized
a False Discovery Rate (FDR) to identify statistical significance. FDR corrected p-values were
considered statically significant if <0.05. All analyses were conducted in SAS 9.
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RESULTS
Baseline demographic and dietary data
Individuals consuming greater amounts of total, regular and nonfat dairy products were
significantly older than those in the first quantile of dairy intake. Greater intakes of nonfat dairy
products had significantly more female participants, fewer smokers, lower education, and lower
total energy intake. (Table 1) Greater consumption of all three dairy exposures had greater
intakes of SMCSFA and LCSFA. Higher consumption of regular/reduced fat dairy products was
also consumed less VLCSFA and PUFA consumption. Participants who consumed greater
amounts of SMCSFA had significantly greater total energy intake, LCSFA, and MUFA
consumption. However, they had significantly less PUFA intake (Table 2).
Participants with greater regular/reduced fat dairy consumption consumed significantly
more milk, cheese, yogurt, and cream compared to the lowest group. Participants in the highest
quartile for nonfat dairy consumed significantly less butter, compared to the lowest group.
(Table 3). Whole and 2% milk products accounted for more than 1/3 of total dairy intake in this
cohort. Other top contributors to dairy intake were cheese, 1% milk products, and frozen dairy
dessert products (Table 4). Most SMCSFA were consumed through cheese and whole milk
(Table 5).
SMCSFA Intake & Cognitive Function
SMCSFA were trending towards beneficial associations when replacing both trans fats
and added sugar related to GCS. [β (95% CI) =0.06(-0.01,0.12) ,p=0.08; β (95% CL)=0.05 (0.01,0.19, p=0.09] cross-sectionally at baseline. FDR indicated these results were no longer
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significant; however, the relationship was trending toward significance (FDR=0.07) (Table 7).
Prospectively, there were no significant observations observed.
Dairy Intake & Cognitive Function
Total dairy and regular/reduced fat dairy were normally distributed but nonfat dairy
distribution was skewed toward 0. The nonfat dairy variable was log-transformed to normalize
the data; however, this did not change the results, so the original skim values were reported.
Dairy components were also skewed. A log transformation was applied to milk, cheese, cream,
and butter. Yogurt contained >50% of participants with 0 values, therefore yogurt was examined
categorically 1) 0 s/day/2000kcal, 2) Less than the median (0.10s/day/2000kcal) or 3) greater
than the median value. The mean baseline total dairy intake was 2.42 s/day, with 2.2 s/day from
regular and reduced fat products and 0.20 servings from nonfat products.
Total, regular/reduced, and nonfat dairy were not significantly related to global cognitive
score cross-sectionally at baseline (Table 7). However, retention was beneficially related to
regular/reduced fat dairy [β (95 % CI) = 0.04 (0.002,0.08), p=0.04] but was no longer significant
after FDR adjustment (FDR=0.70) Retention was also trending toward a positive significant
relationship from total dairy [β (95 % CI) =0.03 (-0.004,0.07), p=0.06] (Supplemental Table 3).
Baseline milk, cheese, cream, and butter were not significantly related to GCS at baseline.
(Table 8) However, individuals who were consuming some yogurt, but less than the median had
significant higher GCS (mean=0.13 ± 0.2) compared to group 1 (mean=0.007 ± 0.12, p<0.001)
and group 3 (mean=0.03 ± 0.02,p=0.003).
When examined prospectively, no significant relationships were observed between total,
regular/reduced, nonfat dairy or SMCSFA and GCS (Table 9) or any of the individual
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neurocognitive tests (Supplemental Table 4). Butter was significantly related to higher GCS [β
(95 % CI) =0.008 (0.008,0.02, p=0.04] and yogurt was trending toward a significant relationship
[β (95 % CI)=0.01 (-0.002,0.03), p=0.07]. This was no longer significant when adjusted for
multiple hypothesis testing (Table 4). We tested yogurt further as a categorical variable because
of the number of participants who consumed 0 servings per day, however, these results were
null. All dairy models were examined with potential mediators, CVD, and diabetes, but the
results did not change.
Additional Analyses
We conducted multiple sensitivity analyses to ensure the accuracy of our results. Crosssectional analyses were run with the final sample (n=345) and total dairy was trending toward
there were no significant differences from the larger sample. Results did not differ when
analyzed with a standard definition of dairy, including only milk, cheese, and yogurt, and
excluding dairy desserts. We examined substitution analysis for servings of dairy at the expense
of servings of red and processed meat and the results were null (Supplemental Table 5)
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DISCUSSION
In contrast to our hypothesis, SMCSFA total dairy, regular and reduced fat dairy, and
nonfat dairy were not significantly associated with cognitive function over 13 years of follow-up
in Puerto Rican adults living in the Boston metro area. When examining the individual dairy
components prospectively, butter was significantly related to GCS, however, this relationship
was attenuated when adjusted for multiple hypothesis testing. Cross-sectionally at baseline,
SMCSFA were positively trending toward a significant beneficial relationship with GCS. Total,
regular & reduced, and nonfat dairy were not significantly related to GCS, however, yogurt was
significantly related to GCS when expressed categorically.
In the current study, results suggested that SMCSFA were positively associated with
global cognitive function when substituted for an equal caloric amount of trans fatty acids.
However, these associations were attenuated in prospective analyses with 13 years of follow-up.
In a prior study conducted by Karazurna et al 24 in the HCHS/SOL study, a dietary fatty acid
pattern consistent with high SMCSFA consumption was beneficially associated with global
cognitive function in a cross-sectional analysis amongst 8,942 Hispanic/Latino adults living in
the US. A prospective analysis was not conducted in that study. Although our results are
consistent with the cross-sectional analysis in the HCHS/SOL study, our longitudinal analysis
does not support the benefit of dietary SMCSFA on cognitive function.
To our knowledge, this is the first prospective cohort study to examine the associations
between SMCSFA and cognitive function or dementia. Our literature review identified that
previous studies examining this relationship have been conducted in animals or control trials,
most of which have observed positive associations between SMCSFA and cognitive
function.24,36,46-53 We built upon this emerging evidence in examining the associations
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longitudinally. The cross-sectional associations observed in our study were consistent with
previous research, but the null prospective relationships may be due to reverse causation. It is
possible that individuals with higher cognitive function scores would be more likely to choose
foods based on their nutritional health components, such as dairy, a major source of SMCSFA.
Our results highlight the importance of conducting prospective studies to clarify the
directionality of associations.
Regardless, there is building evidence to suggest that short and MCSFA may benefit
cognitive functioning. An RCT in rats with early-stage dementia found that the administration of
15 mg/kg of body weight NaB per day for 12 weeks, compared to the control group who did not
receive this, improved cognitive measures including decreased amyloid-β peptides in the brain
and increased fear response.44 A separate RCT conducted in rats with advanced dementia found
significant improvements in memory when NaB was administered.50 Similar findings have been
observed in human RCTs. Ota et al 52 examined the effects of a 20g combination of caprylic acid
and capric acid, two SFAs, on cognitive function in Japanese adults (n=20) with mild to
moderate AD. Investigators found that after 8 weeks, participants improved both immediate and
longer-term memory scores. After 12 weeks, investigators continued to see improvements in
neurocognitive testing, including digit testing. To our knowledge, the current study is the first to
examine SMCSFA prospectively.
The relationship between SMCSFA may be due to anti-inflammatory effects, as well as
MCSFA’s ability to synthesize ketones for energy Studies have found that MCSFA
downregulates the receptor responsible for stimulating the release of inflammatory cytokines,
decreasing systemic inflammation.77 Inflammatory markers, such as IL-6 and TNF-α promote
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oxidative stress and decreased endothelial cell function of the blood-brain barrier, decreasing
cognitive function in the brain.78 Furthermore, research suggests that MCSFA can improve
cardiometabolic risk factors, including insulin resistance.79, It is known that the brain requires
energy to function, primarily glucose. During a state of insulin resistance and low glucose
availability to the brain, MCSFA are absorbed into the intestines and are able to cross the bloodbrain barrier, and become metabolized into ketones, an alternative source of energy for the
brain.79 It is hypothesized that the availability of the ketones from the MCSFAs to the brain may
be beneficial for cognitive functioning as an energy source for cognitive functioning, especially
during times of insulin resistance in the brain.79 The documented effects of SMCSFA on the
cardiometabolic risk factors may improve cognitive function.
Considering the prior evidence suggesting that SMCSFA consumption may improve
cardiometabolic risk factors of cognitive decline,18,35,36 we additionally examined dairy
consumption. Karazurna et al24 reported that dairy products were the main source of SMCSFA in
the diets of Hispanic/Latino adults. Prospectively, butter was beneficially related to GCS. Crosssectionally, yogurt was significantly beneficial to GCS. While FDR corrections attenuated the
relationship, these results remain suggestive of a potential benefit. When compared by fat type of
dairy product, there were no significant relationships observed with GCS.
Our findings contrast other observational studies that found dairy was associated with better
cognitive functioning. In 2003, Yamanda et al80 examined potential risk factors for dementia in
Japanese older adults who had survived the atomic bombings in 1945 (n=1,774). Researchers
reported a significant reduction in risk of Japanese older adults for dementia in participants who
reported consuming milk at least 4 times per week, as compared to those who consumed less.
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Similar results were observed in a separate cohort study examining milk and dairy with dementia
in older Japanese adults (n=1,081) over 17 years of follow-up.61 There was a significant inverse
association between milk and dairy consumption and risk of dementia. De Gogi et al 58 found
that skim dairy, fermented dairy, and buttermilk were significantly associated with higher
executive functioning. Furthermore, this study found that 30g of cheese decreased the probability
of low processing speeds.
Studies have also found adverse associations between dairy intake and cognitive functioning.
Petruski-Ivelva et al 62 found that US adults who consumed greater amounts of milk were at
greater risk of cognitive decline over 20 years. However, the authors note that 75% of reported
milk intake was from skim milk products. Furthermore, the authors analyzed total dairy intake by
race and there were no significant differences between quartiles of dairy intake in white or black
Americans. A cross-sectional study examining dairy intake and cognitive function in Australian
men found that whole fat cream, whole fat cheese and low-fat cheese were associated with
poorer memory and an increase in cognitive failures.57 This study was subject to confounding
and recall bias. Dairy was expressed as crude servings per day, which does not account for
different energy needs between different people. Non-energy-adjusted dairy variables may
contribute to the deleterious effects of dairy, as higher total energy intake has previously been
associated with poorer health outcomes.81 Furthermore, this study also collected cognitive data
using the Cognitive Failures Questionnaire, in which participants self-reported their cognitive
abilities. These methodological components may have contributed to the negative associations
observed between dairy and cognitive function.
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Our results are in support of recent meta-analyses and other prospectively designed studies
that have found null associations between total dairy and global cognitive functioning.82 KesseGuyot et al73 reported null associations between total dairy intake or individual dairy components
and cognitive functioning in a cohort study of French adults (n=3,076). However, authors did
identify that in women, individuals who consumed less than or greater than French Dietary
Guidelines significantly decreased both working and verbal memory, as compared to individuals
who are meeting the recommendations. We built upon prior studies examining the impact of
dairy on cognitive function by examining these associations in a Puerto Rican adult cohort.
Evidence suggests that Puerto Ricans, as compared to other Hispanic/Latino Groups, experience
a higher prevalence of cognitive impairment and cardiometabolic health conditions. Collectively,
our findings suggest that total dairy consumption may not affect older Puerto Rican adults.
Total dairy was not significantly related to cognitive functioning; however, butter was
significantly beneficial to GCS prospectively. Although when adjusted for multiple hypotheses
testing the significance was attenuating, this is still suggestive of a beneficial relationship. Butter
has been controversial in its relationship to CVD, however, recent findings suggest that butter
may not be detrimental to cardiovascular health. Recent evidence has found that total dairy
intake, including butter, decreased risk of CVD death, cardiovascular diseases, and stroke.83
Butter consumption was low, and no statistical significance was observed with butter on its own.
There are very limited studies examining butter and cognitive function. In a recent prospective
analysis, Granic et al84 found that participants who consumed high amounts of butter were
significantly more likely to be considered impaired, compared to those who consumed low meat,
but less likely compared to those who consumed high amounts of red meat, determined through
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cluster analysis. The authors did not disclose specific quantities of each food product consumed.
Butter intake was not significantly associated with cognitive decline over 5 years of follow-up.
There are several reasons that may explain the null associations of SMCSFA and dairy with
cognitive functioning. Cognitive decline takes time to develop and may require a longer study
duration to observe the cognitive decline progression. The Alzheimer’s Association suggests that
the onset of dementia can vary drastically between individuals, ranging from months to years
from the identification of symptoms to death from some form of cognitive impairment.85 Some
studies that have found beneficial associations have been conducted over a longer duration
compared to the current study. In 2019, McEvoy et al 86 examined the effects of the adherence to
the Dietary Approach to Stop Hypertension, the Mediterranean Diet, or the A Priori Diet Quality
Score diet at baseline age of 25 and cognitive functioning at 25- and 30-year follow-ups, utilizing
the Coronary Artery Risk Development in Young Adults cohort study. Higher dietary scores
were significantly associated with cognitive outcomes at 25 years. However, the cognitive
change over 5 years from years 25-30 was not significant. This may indicate that a longer
follow-up period is necessary to observe changes in cognitive function. A separate prospective
analysis followed Finish adults over a mean of 22 years and observed a 28% reduction of risk for
dementia associated with the top quartile of cheese consumption compared to the lowest.87 This
study also suggests the need for a longer follow up. In the current study, participants were
followed for a mean of 12.6 ± 1.13 years. Evidence suggests that longer follow-up may be
necessary to observe significant changes on cognitive function.
There may be the potential for loss to follow-up bias within our final sample. At the 13-year
visit, a sub-sample of BPRHS participants (517 of 1491 at baseline) returned for dietary
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assessment and cognitive testing. It is possible that individuals who were experiencing cognitive
decline or developed cognitive impairment did not return for the 13-yr study visit due to the
cognitive burden of the study-related activities. Participants in who did not return to the study
had significantly lower GCS compared to those who did (p=0.006). Participants were
significantly older (p <0.003) and had a greater prevalence of diabetes (p=0.01) (Supplementary
Table 2). Thus, the analytical sample in the prospective analysis were healthier both with a
lower prevalence of diabetes and significantly higher global cognitive score, more likely to be
female, and younger as compared to those who elected to not return because of these significant
differences in those who dropped out of the study. These differences may play a significant role
in why null observations were observed.
There was low overall reported consumption of SMCSFA and dairy, which also may have
contributed to the null associations. SMCSFA consumption in the current study was similar to
the reported intake in the HCHS/SOL but may not meet a threshold amount needed to see
benefits longitudinally.24 In a recent RCT in young adults, participants were administered 12g or
18g of MCT for 4 weeks.77 Cognitive function was measured through a battery of tests once per
week. There was a significant improvement in both experimental groups, as compared to the
control group who did not consume the MCT supplement. Participants in the current study were
consuming an average of less than 1g per day of MCT. Similarly, dairy intake may have been too
low to be associated with changes in cognitive function. Previous prospective studies have
suggested that consuming less than the recommended daily intakes may be adversely related to
cognitive functioning.74 Furthermore, De Goeij et al58 reported median intake of 30g/day for
milk, 90g per day of yogurt, and 31g per day of total cheese when examining the cross-sectional
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associations of dairy with cognitive performance. Researchers found a significant relationship
between a 30g increase of cheese per day and improved processing speeds. The current study
reported consuming median intakes of 0.95 servings of milk/day, 0.39 servings of cheese per
day, and 0.03 servings of yogurt per day. This would be equivalent to about 232 g/day of milk,
11g/day of cheese, and about 7g/day of yogurt per day. The lower intakes of cheese and yogurt
within this population may be contributing to the null results. As mentioned previously, a
prospective study in Finish adults over a 22-year follow-up found that cheese intake in the top
quartile (31g/day) was at a significantly decreased risk of dementia compared to the bottom
quartile (0.7g/day).87 In the current study, average dairy intake fell below the US Dietary
Guidelines Recommendation of 3cups/day/2000kcal. These studies may suggest that nutrients
specifically found in cheese may be beneficial for cognitive functioning, and the current cohort
did not meet the threshold amount.
Although our study is one of the first to examine SMCSFA and dairy consumption and
cognitive function among Hispanic/Latino adults, our sample is relatively small. Our
prospective analysis was conducted in 345 Puerto Rican adult participants but may not be large
enough to detect statical power. Other studies that have observed a significant relationship have
been conducted in cohorts with greater than 345 participants. A prospective study conducted in
13,751 US adults between 45 and 64 years old identified a significant relationship between total
milk intake and cognitive decline.62 Similar findings were observed in other epidemiological
studies with larger samples sizes than the current study.73,81
We considered the potential for differential effects among those with diabetes. Insulin
resistance has been previously reported to impede cognitive function through endothelial cell
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damage and decreased insulin sensitivity in the brain.87 Previous research conducted in Puerto
Ricans has found that the Mediterranean Diet may benefit cognitive function in participants with
diabetes.88 In the current study, there were no associations between SMCSFA or dairy exposures
and GCS in participants who had self-reported diabetes (n=267) at any time point. This may
suggest that a nondairy component of the Mediterranean diet was beneficial in improving
glycemic control.
In addition to the aforementioned limitations of the study, specifically length of followup, loss to follow-up bias, the timing of dietary assessment, and sample size, there are a few
additional limitations to consider. There is the potential for error in the neurocognitive testing
procedure. Participants cognition may not be accurately represented due to measurement error or
interviewer bias. Future studies should consider a more precise measure of brain function, such
as functional magnetic resonance imaging or brain volume measurements. Diet was self-reported
which may lead to measurement error if participants are not accurately representing their actual
intake. However, the FFQ was validated for this population, which minimizes the
misclassification bias of the exposure. Previous studies have utilized adipose tissue 15:0 and
17:0 as nutritional biomarkers for dairy intake and should be considered for future analyses.90
There are several strengths of the current study. This study was conducted amongst
Puerto Rican adults, an underrepresented group in current literature. The prospective study
assessments and validation of the FFQ minimize the risk of misclassification bias. We also
minimized bias by adjusting models for multiple confounding variables.
In conclusion, when accounting for multiple hypothesis testing within our study, there
was no associations between SMCSFA and dairy with cognitive functioning in Puerto Rican
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adults. This population is at an increased risk of developing some form of cognitive decline,
potentially due to their high rates of diabetes and CVD. Longer prospective studies with larger
sample sizes should be conducted within this population to determine dietary interventions that
may be protective against cognitive decline.
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APPENDIX A
TABLES & FIGURES
Table 1. Demographic data by dairy and SMCSFA quartile at baseline (n=345).
Q1

Q2

Q3

Q4

Total Dairy (s/day)
Age (years)
Female (%)
Smoker (%)
High School Education (%)
Physical Activity Level
CVD (%)
Diabetes (%)

1.08±0.06
55.1 ± 0.69
74.8
29.9
15.6
30.8 ± 0.41
20.0
31.0

1.86±0.06
53.8± 0.69
74.5
14.8
21.1
32.6 ± 0.415
11.7
38.2

2.54±0.06
55.6± 0.69
78.1
22.0
17.2
31.8 ± 0.41
19.8
29.8

4.35±0.03
57.3 ± 0.69*
83.6
17.2
19.8
32.1 ± 0.42
19.9
30.5

Regular/Reduced Fat Dairy (s/day)
Age (years)
Female (%)
Smoker (%)
High School Education (%)
Physical Activity Level
CVD (%)
Diabetes (%)

0.98±0.06
55.7 ± 0.69
77.8
25.4
18.0
31.1 ± 0.42
19.1
29.4

1.69±0.06
53.0±0.69
75.9
19.5
22.0
32±0.42
11.6
35.5

2.32±0.06
55.0±0.69
75.8
15.8
16.0
31.8±0.41
22.8
34.1

3.85±0.06
57.1 ± 0.69*
81.5
16.7
17.5
31.9 ± 0.42
17.8
30.5

Nonfat Dairy (s/day)
Age (years)
Female (%)
Smoker (%)
High School Education (%)
Physical Activity Level
CVD (%)
Diabetes (%)

0.01±0.03
53.9 ± 0.70*
67.8
33.7
8.34
31.9 ± 0.42
14.8
22.5

0.04±0.03
55.4±0.70
78.2
22.9
23.9
31.8±0.41
18.8
33.1

0.08±0.03
56.0±0.70
79.0
17.2
19.1
31.3 ±0.42
23.9
37.2

0.68±0.02
56.7 ± 0.7*
86*
10.1**
21.9
32.2 ± 0.42
13.8
36.6*

SMCSFA (%TE)
Age (years)
Female (%)
Smoker (%)
High School Education (%)
Physical Activity Level
CVD (%)
Diabetes (%)

0.31 ± 0.01
55.8 ± 0.70
76.7
23.3
13.8
31.4±0.42
19.1
29.4

0.50±0.01
54.0±0.70
80.8
22.1
21.3
31.7±0.42
14.8
36.6

0.70±0.01
55.9±0.70
75.8
18.9
20.0
32.2±0.42
20.7
31.6

1.1 ± 0.02
56.1 ± 0.70
77.6
19.5
18.2
31.8±0.42
16.7
31.8

Trend analyses were conducted to determine statistical differences between quartiles. Total dairy includes milk, cheese,
yogurt, cream, and butter. Regular dairy includes full-fat dairy products. Reduced fat includes 1% and 2% dairy products.
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Nonfat dairy includes skim or 0% fat products. Dairy variables are energy adjusted servings per day and SMCSFA is
expressed as a % TE. SMCSFA= short and medium chain saturated fatty acids, TE= total energy, CVD=cardiovascular
disease * indicates p<0.05, ** indicates p <0.001

Table 2. Dietary data by dairy and SMCSFA quartile at baseline (n=345).
Q1

Q2

Q3

Q4

Total Dairy (s/day)
TE (kcal/day)
SMCSFA (% TE)
LCSFA (% TE)
VLCSFA (% TE)
MUFA (% TE)
PUFA (% TE)
Fruit (s/day)
Vegetables (s/day)
Sugar (% TE)

2060 ± 106
0.36 ± 0.02
7.82 ±0.02
9.53±0.01
11.1±0.02
9.44±0.02
2.23 ± 0.17
2.10 ± 0.12
9.49 ± 0.58

2350 ± 106
0.51 ± 0.02
8.37±0.02
8.94±0.01
11.2±0.02
8.84±0.02
2.24 ± 0.17
2.31 ± 0.12
10.5 ± 0.58

2240 ± 106
0.73 ± 0.02
9.34±0.02
8.73±0.01
11.2±0.02
8.56±0.02
2.12 ± 0.17
2.06 ± 0.12
10.7 ± 0.58

2270 ± 107
0.99 ± 0.02**
10.1±0.02
8.48±0.01
10.8±0.02
7.18±0.02**
2.07 ± 0.17
1.85 ± 0.10
10.2 ± 0.56

Regular/Reduced Fat (s/day)
TE (kcal/day)
SMCSFA (% TE)
LCSFA (% TE)
VLCSFA (% TE)
MUFA (% TE)
PUFA (% TE)
Fruit (s/day)
Vegetables (s/day)
Sugar (% TE)

2040 ± 107
0.33 ± 0.02
7.51±0.02
9.83±0.01
10.9±0.02
9.15±0.02
2.34 ± 0.17
2.2 ± 0.12
9.66 ± 0.57

2270 ± 107
0.53 ± 0.02
8.51±0.02
8.73±0.01
11.2±0.02
8.98±0.02
2.24 ± 0.17
2.34 ± 0.116
9.66 ± 0.58

2320 ± 106
0.702 ± 0.02
9.23±0.02
8.76±0.01
11.2±0.02
8.53±0.02
2.02 ± 0.17
2.03 ± 0.114
11 ± 0.571

2290 ± 107
1.04 ± 0.02**
10.4±0.02**
8.35±0.01*
11.0±0.02
7.36±0.02**
2.06 ± 0.17
1.75 ± 0.12
10.6 ± 0.58

Nonfat dairy (s/day)
TE (kcal/day)
SMCSFA (% TE)
LCSFA (% TE)
VLCSFA (% TE)
MUFA (% TE)
PUFA (% TE)
Fruit (s/day)
Vegetables (s/day)
Sugar (% TE)

2230 ± 106
0.63 ± 0.03
9.07±0.02
8.41±0.01
11.3±0.02
8.95±0.02
2.09 ± 0.17
2.04 ± 0.12
9.85 ± 0.58

2270± 107
0.53 ± 0.02
8.51±0.02
8.73±0.01
11.2±0.02
8.98±0.02
2.24 ± 0.17
2.34 ± 0.12
9.66 ± 0.58

2320± 107
0.702 ± 0.02
9.23±0.02
8.76±0.01
11.2±0.02
8.53±0.02
2.02 ± 0.17
2.03 ± 0.11
11.0 ± 0.57

2010 ± 106*
0.61 ± 0.03
8.20±0.02*
8.48±0.01
10.3±0.02**
7.50±0.02**
2.61 ± 0.17*
2.41 ± 0.12*
9.23 ± 0.58

SMCSFA (%TE)
TE (kcal/day)
LCSFA (% TE)
VLCSFA (% TE)

1970±10.5
7.0±0.01
9.2±0.01

2140± 10.5
8.46±0.01
9.26±0.01

2430 ±10.5
9.17±0.01
8.73±0.01

2380±10.5*
11.00±0.01**
8.48±0.01
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MUFA (% TE)
PUFA (% TE)
Fruit (s/day)
Vegetables (s/day)
Sugar (%TE)

10.4±0.21
8.91±0.02
2.54±0.17
2.51±0.11
9.04±0.57

11.2±0.21
9.23±0.01
2.0±0.17
2.26±0.11
9.87±0.57

11.2±0.21
8.24±0.01
2.11±0.17
1.87±0.11
11.2±0.57

11.5±0.21*
764±0.02**
2.01±0.17
1.69±0.11
10.8±0.57*

Trend analyses were conducted to determine statistical differences. Total dairy includes milk, cheese, yogurt, cream, and
butter. Regular dairy includes full fat dairy products. Reduced fat includes 1% and 2% dairy products. Nonfat dairy includes
skim or 0% fat products. SMCSFA= short and medium chain saturated fatty acids, TE=total energy, LCSFA=long chain
saturated fatty acids, VLCSFA= very-long chain saturated fatty acids, MUFA= monounsaturated fatty acids,
PUFA=polyunsaturated fatty acids . * indicates p<0.05, ** indicates p <0.001

Table 3. Baseline dairy component intake by dairy quartile (n=345).
Dairy (s/day)
Total Dairy
Dairy components
Milk (s/day)
Cheese (s/day)
Yogurt (s/day)
Cream (s/day)
Butter (s/day)

Regular/Reduced Fat Dairy

Nonfat dairy

Q1

Q4

Q1

Q4

Q1

1.08±0.03

4.35±0.03

0.98±0.03

3.98±0.03

0.01±0.02

0.43 ± 0.05
0.30 ± 0.02
0.05 ± 0.01
0.10 ± 0.02
0.20 ± 0.02

2.55 ± 0.05**
0.64 ± 0.02**
0.24 ± 0.01**
0.51 ± 0.03**
0.42 ± 0.02**

0.55±0.05
0.29±0.02
0.08±0.01
0.08±0.03
0.20±0.02

2.31±0.05**
0.65±0.02**
0.19±0.01**
0.52 ±0.03**
0.44±0.02

0.08±0.06
0.50±0.02
0.07±0.01
0.29±0.03
0.36±0.02

Trend analyses were conducted to identify statistical significance between quartiles. * Indicates p <0.05, ** indicates p
<0.001.

Table 4. Top 10 contributors to total dairy intake at baseline (n=345).
Food

% Total dairy

2% Milk
Whole milk
Cheese
1% or skim milk
Frozen dairy dessert
Yogurt
Butter
Potato dishes
Cakes and candy
Breads

18.78
18.78
16.89
9.41
8.69
4.52
3.87
3.68
2.77
1.94

Top foods were estimated by proc rank by groups of foods. Top 10 contributors were
included.
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Table 5. Top 10 contributors to SMCSFA intake at baseline (n=345).
Food

% Total SMCSFA

Cheese
Whole milk
2% milk
Frozen dairy dessert
Potato dishes
Yogurt
Cakes and candy
Butter
Pizza
Nuts

29.94
22.14
13.71
7.14
2.89
2.82
2.57
2.49
1.83
1.60

Top foods were estimated by proc rank by groups of foods. Top 10 contributors were
included. SMCSFA=short and medium chain saturated fatty acids.

Table 6. Individual neurocognitive test means at baseline (n=345)
Test

Mean ± SE

GCS
Digit Span Forward
Digit Span Backward
Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
Figure Copying

0.12 ± 0.02
7.60 ± 0.10
3.60±0.07
2.21 ±0.05
38.9±0.50
30.2±0.27
84.1 ±1.37
34.12±0.08
25.09±0.50
11.22±0.36

Individual tests were z-score transformed to be standardized to create global cognitive functioning score
(GCS).
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Table 7. Cross-sectional associations of dairy and SMCSFA with GCS (n=1292) at baseline
β-coefficient (95% CI)
Total Dairy
Regular/Reduced Fat Dairy
Nonfat Dairy
SMCSFA Factor Score
SMCSFA Substitution Models
trans fats
Added sugar

P-value

0.01 (-0.01, 0.03)
0.01 (-0.01, 0.03)
-0.01(-0.05, 0.04)
0.02 (-0.01,0.04)

0.27
0.20
0.83
0.23

0.06(-0.01, 0.10)
0.105(-0.01, 0.12)

0.08
0.09

Proc reg was used to run a cross-sectional multiple linear regression model with dairy and SMCSFA with GCS at baseline.
Dairy models were adjusted for age, sex, education, total energy, physical activity and smoking status at baseline and baseline
intake of added sugar, fruit, and vegetables. SMCSFA factor score was derived using Karazurna et al factor 2 score 24. GCS
was calculated as the composite score of individual z-score transformed cognitive tests. This model was adjusted for age, sex,
education, total energy, physical activity, and smoking status. SMCSFA substitution models were adjusted for the
aforementioned covariates. Substitution at the expense of trans fats held all other dietary covariates constant, including total
carbohydrate, total fat, total protein, total alcohol, long chain saturated fats, very-long chain saturated fats, monounsaturated
fats, and polyunsaturated fats. Substitution at the expense of added sugar held the previously mentioned dietary covariates
constant as well as trans fats and carbohydrates minus those from added sugar. There were not significant findings.

Table 8. Cross-sectional analysis of dairy components with GCS at baseline (n=1292).
Milk
Cheese
Butter
Cream

β-coefficient (95% CI)

P-value

0.004 (-0.02, 0.03)
0.01(-0.01, 0.04)
0.01 (-0.01, 0.03)
-0.01 (-0.02, 0.01)

0.74
0.32
0.45
0.55

Proc reg was used to run a cross-sectional multiple linear regression model with milk, cheese, butter and cream. Because of
many non 0 values, yogurt was analyzed as a categorical variable, described elsewhere. GCS was calculated as the composite
score of individual z-score transformed cognitive tests. Models were adjusted for age, sex, education, total energy, physical
activity and smoking status at baseline, baseline intake of added sugar, fruit, and vegetables . There were no significant
relationships observed.
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Table 9. Prospective associations of dairy and SMCSFA with GCS (n=345).
Total Dairy
Regular/Reduced Fat Dairy
Nonfat Dairy
SMCSFA Pattern Score
SMCSFA

Model

β-coefficient (95% CI)

P-value

trans fats
Added sugar

0.0003 (-0.002, 0.003)
0.01 (-0.002, 0.003)
-0.002 (-0.01, 0.01)
0.002 (-0.002,0.01)
0.001 (-0.001, 0.004)
0.001 (-0.001, 0.004)

0.83
0.71
0.65
0.26
0.40
0.39

Proc mixed was used to conduct mixed-effect models. Dairy components were estimated at baseline, 2 and 13 years. Total
dairy includes milk, cheese, yogurt, cream, and butter. Regular dairy includes full fat dairy products. Reduced fat includes 1%
and 2% dairy products. Nonfat includes skim or 0% fat products. GCS was calculated as the composite score of individual zscore transformed cognitive tests. Models were adjusted for age, sex, education, and time covarying total energy, physical
activity and smoking status, and intake of added sugar, fruit, and vegetables. SMCSFA Pattern score was derived with factor
scores derived from Karazurna et al.24 The dietary pattern score models were adjusted for age, sex, education, time covarying
total energy, physical activity, and smoking status. SMCSFA were also analyzed as substitution analyses at the expense of
trans fats and added sugar. Substitution models were adjusted for total fat, total carbohydrate, and total protein. Substitution
model at the expense of added sugar adjusted for trans-fat covariates plus trans fats, and carbohydrate intake minus added
sugar. There were no statistically significant findings.

Table 10. Prospective analysis of dairy components with GCS at baseline (n=345).
β-coefficient (95% CI)
Milk

P-value

-0.002 (-0.005,0.002)

0.39

0.01 (-0.002,0.03)

0.07

Yogurt

b

-0.002 (-0.008,0.003)

0.45

Yogurt

c

0.01 (-0.001, 0.01)

0.59

-0.002 (-0.009,0.004)
0.008 (0.0002, 0.02)
-0.001 (0.005, 0.003)

0.47
0.04
0.59

Yogurt

Cheese
Butter
Cream

Proc mixed was used to conduct mixed-effect models. Dairy components were estimated at baseline, 2 and 13 years. There
were no statistically significant findings. Total dairy includes milk, cheese, yogurt, cream, and butter. Regular dairy includes
full fat dairy products. Reduced fat includes 1% and 2% dairy products. Nonfat includes skim or 0% fat products. GCS was
calculated as the composite score of individual z-score transformed cognitive tests. Model 1 was adjusted for age, sex,
education, and time covarying total energy, physical activity and smoking status Model 2 was adjusted for model 1 covariates
plus time covarying intake of added sugar, fruit, and vegetables.
a analyzed as a continuous variable in using proc mixed. b compared high consumers of yogurt to low and non consumers. c
compared low consumers with high and non consumers.

Supplemental Table 1. Saturated Fatty Acid Chain Length Categorization
Fatty Acid Group

Individual species names (Carbon chain length)

Short chain SFA
Medium-chain SFA
Long-chain SFA
Very-long chain SFA

Butyric acid (C4)
Caproid acid (C6), Caprylic acid (C8), Capric acid (C10), Lauric acid (C12)
Myristic (C14), Palmitic acid (C16), Stearic acid (C18)
Arachidonic acid (C20), Behenic acid (C22)
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Supplemental Table 2. Demographic and dietary covariates comparing participants who were in the final
sample versus those who dropped out.
Variable
Final Sample(n=345)
Lost to Follow-up (n=947)
P-value
Age
Sex (%)
GCS
Total dairy (s/day)
SMCSFA (%TE)
Physical activity level
Education level (%)
Smoking status (%)
Diabetes (%)
CVD (%)

55.5±0.35
77.8
0.12±0.02
2.42±0.06
0.65±0.02
31.8±0.21
18.3
20
32.4
17.8

57.1±0.26
68.3
0.02±0.02
2.52±0.04
0.66 ±0.01
31.7±0.17
15.7
25.4
40
21.2

0.0003*
0.0006*
0.006*
0.21
0.57
0.79
0.24
0.08
0.01*
0.14

Proc GLM was used to determine statistical significance between group means. * Indicates p<0.05. GCS= Global Cognitive
Score SMSFA= short and medium chain saturated fatty acid, TE= total energy, CVD=cardiovascular disease. * Indicates
p<0.05

Supplemental Table 3. Cross-sectional associations of dairy and SMCSFA with individual neurocognitive
tests at baseline (1292).
Exposure
Total Dairy

Regular/Reduced Fat Dairy

Nonfat Dairy

Test
Digit Span Forward
Digit Span Backward
Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
Figure Copying
Digit Span Forward
Digit Span Backward
Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
Figure Copying
Digit Span Forward
Digit Span Backward
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β-coefficient (95% CI)

P-value

0.02 (-0.01, 0.06)
0.01 (-0.02, 0.04)
0.01 (-0.02, 0.05)
0.02 (-0.01, 0.05)
0.03 (-0.004, 0.07)
-0.003 (-0.04, 0.03)
0.01 (-0.02, 0.05)
-0.004 (-0.04, 0.03)
-0.002 (-0.03, 0.03)
0.02 (-0.01, 0.06)
0.01 (-0.02, 0.04)
0.01 (-0.01, 0.05)
0.02 (-0.01, 0.06)
0.04 (0.002, 0.08)
-0.002 (-0.04, 0.03)
0.01 (-0.02, 0.05)
-0.01 (-0.05, 0.02)
0.006 (-0.03, 0.04)
0.02 (-0.06, 0.12)
0.01 (-0.07, 0.10)

0.13
0.58
0.42
0.31
0.09
0.87
0.55
0.79
0.90
0.18
0.64
0.34
0.23
0.04
0.89
0.45
0.47
0.72
0.52
0.76

Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
Figure Copying

-0.01 (-0.01, 0.07)
-0.01 (-0.09, 0.07)
-0.02 (-0.12, 0.06)
-0.005 (-0.09, 0.08)
-0.01 (-0.11, 0.08)
0.04 (-0.04, 0.13)
-0.04 (-0.13, 0.04)

0.83
0.78
0.62
0.91
0.79
0.32
0.27

Proc reg was used to run a cross-sectional multiple linear regression models. Total dairy includes milk, cheese, yogurt, cream,
and butter. Regular dairy includes full fat dairy products. Reduced fat includes 1% and 2% dairy products. Nonfat dairy
includes skim or 0% fat products. GCS was calculated as the composite score of individual z-score transformed cognitive
tests. Models were adjusted for age, sex, education, total energy, physical activity and smoking status at baseline, and baseline
intake of added sugar, fruit, and vegetables. *p <0.05, however; FDR corrections were applied to adjust for multiple
hypothesis testing and attenuated significant findings.

Supplemental Table 4. Prospective analysis of dairy and SMCSFA and GCS at baseline, 2 and 13 years
(n=345).
Test
β-coefficient (95% CI)
P-value
Total Dairy

Regular/Reduced fat dairy

Nonfat Dairy

Digit Span Forward
Digit Span Backward
Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
Figure Copying
Digit Span Forward
Digit Span Backward
Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
Figure Copying
Digit Span Forward
Digit Span Backward
Clock Drawing
Word List Learning
Retention
Recognition
Stroop
Verbal Fluency
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-0.002 (-0.01, 0.004)
-0.003 (-0.009, 0.003)
-0.002 (-0.01, 0.004)
0.002 (-0.005, 0.01)
0.004 (-0.003, 0.01)
-0.002 (-0.01, 0.004)
-0.003 (-0.01, 0.004)
0.003 (-0.002, 0.01)
0.004 (-0.001, 0.01)
-0.0001(-0.01, 0.01)
-0.002 (-0.01, 0.005)
-0.002 (-0.01, 0.004)
0.002 (-0.004, 0.01)
0.004 (-0.003, 0.01)
-0.002 (-0.01, 0.01)
-0.004 (-0.01, 0.003)
0.01 (-0.001, 0.01)
0.01 (-0.001, 0.01)
-0.01 (-0.02, 0.01)
-0.01 (-0.02, 0.004)
-0.0003 (-0.01, 0.01)
0.0002 (-0.01, 0.01)
0.005 (-0.01, 0.02)
-0.002 (-0.02, 0.01)
0.00272 (-0.01, 0.02)
-0.01 (-0.02, 0.01)

0.6
0.31
0.53
0.56
0.22
0.52
0.41
0.31
0.14
0.98
0.62
0.51
0.5
0.31
0.57
0.31
0.1
0.12
0.21
0.14
0.96
0.98
0.58
0.82
0.78
0.2

Figure Copying

-0.001 (-0.01, 0.01)

0.85

Proc mixed was used to conduct mixed-effect models. Dairy components were estimated at baseline, 2 and 13 years. Total
dairy includes milk, cheese, yogurt, cream, and butter. Regular dairy includes full fat dairy products. Reduced fat includes 1%
and 2% dairy products. Nonfat includes skim or 0% fat products. GCS was calculated as the composite score of individual zscore transformed cognitive tests. Models were adjusted for age, sex, education, and time covarying total energy, physical
activity and smoking status, and intake of added sugar, fruit, and vegetables. GCS was calculated as the composite score of
individual z-score transformed cognitive tests. Models were adjusted for age, sex, education, total energy, physical activity
and smoking status at baseline, and baseline intake of added sugar, fruit, and vegetables. *p <0.05, however; FDR corrections
were applied to adjust for multiple hypothesis testing and attenuated significant findings.

Supplemental Table 5. Prospective substitution of dairy at the expense of red meat with GCS (n=345)
Total Dairy
Regular/Reduced Fat Dairy
Nonfat Dairy

β-coefficient (95% CI)

P-value

0.0004 (-0.002, 0.003)
0.01 (-0.002, 0.003)
-0.002 (-0.01, 0.01)

0.78
0.66
0.63

Proc mixed was used to conduct mixed-effect models. Total dairy includes milk, cheese, yogurt, cream, and butter. Regular
dairy includes full fat dairy products. Reduced fat includes 1% and 2% dairy products. Nonfat includes skim or 0% fat
products. GCS was calculated as the composite score of individual z-score transformed cognitive tests. Models were adjusted
for age, sex, education level, and time covarying smoking status, physical activity level, total servings of fruit, vegetables,
grains, legumes, animal proteins, oils, and alcohol, per day. There were no statistically significant findings.
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